Supernus Pharmaceuticals, Inc. trades by members of Congress

Purchases and sales of Supernus Pharmaceuticals, Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 2 trades Reported value $2,002–$30,000 (sum of the ranges filed)

Sales, last 12 months 0 trades None disclosed

Members trading, last 12 months 1 9 purchases and sales since January 3, 2015

Supernus Pharmaceuticals, Inc. trades disclosed by members of Congress
				Report
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Apr 7, 2026	Mar 3, 2026	Filing for SUPN on Mar 3, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Jan 12, 2026	Dec 11, 2025	Filing for SUPN on Dec 11, 2025
Gilbert Ray Cisneros, Jr. House · D-CA 31	Sale (partial)$1,001 - $15,000	Nov 18, 2025	Oct 9, 2025	Filing for SUPN on Oct 9, 2025
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Apr 7, 2025	Mar 24, 2025	Filing for SUPN on Mar 24, 2025
Josh Gottheimer House · D-NJ 5	Sale (partial)$1,001 - $15,000 · Joint	Jan 13, 2023	Dec 23, 2022	Filing for SUPN on Dec 23, 2022
Gilbert Ray Cisneros, Jr. House · D-CA 39	Purchase$1,001 - $15,000	Dec 15, 2020	Nov 13, 2020	Filing for SUPN on Nov 13, 2020
Gilbert Ray Cisneros, Jr. House · D-CA 39	Purchase$1,001 - $15,000	Aug 19, 2020	Jul 17, 2020	Filing for SUPN on Jul 17, 2020
Gilbert Ray Cisneros, Jr. House · D-CA 39	Purchase$1,001 - $15,000	Jun 16, 2020	Jun 1, 2020	Filing for SUPN on Jun 1, 2020
Josh Gottheimer House · D-NJ 5	Purchase$1,001 - $15,000 · Joint	Jun 10, 2020	May 28, 2020	Filing for SUPN on May 28, 2020

When several House members traded Supernus Pharmaceuticals, Inc.

Months when 2 or more House members became net buyers, or 3 or more net sellers, of Supernus Pharmaceuticals, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. Only House members' electronic trade reports are included; Senate reports and reports filed on paper are not. After the 1 buying crowd with six months of prices, it averaged −15.4% against the index. One company's history is too short to judge by; the test across every company is the better guide.

Month	Crowd	3 months on, vs S&P 500	6 months	12 months
June 30, 2020	2 buying	−20.4%	−15.4%	−11.2%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Supernus Pharmaceuticals, Inc. · Insider trading · Funds · All trades by members of Congress